{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:09:44Z","timestamp":1778839784942,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SB\/S2\/RJN-078\/2019"],"award-info":[{"award-number":["SB\/S2\/RJN-078\/2019"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["GAP-2194"],"award-info":[{"award-number":["GAP-2194"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["GAP-1128"],"award-info":[{"award-number":["GAP-1128"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.joim.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:53:12Z","timestamp":1664499192000},"page":"62-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067"],"prefix":"10.1016","volume":"21","author":[{"given":"Sumera","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubashir J.","family":"Mintoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chilakala Nagarjuna","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankul","family":"Kotwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip B.","family":"Bharate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utpal","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip M.","family":"Mondhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.joim.2022.09.006_b0005","first-page":"506","article-title":"Recent trends in screening and evaluation methods of anticancer drugs","volume":"2","author":"Rathod","year":"2012","journal-title":"Indo Am J Pharm Res"},{"issue":"4","key":"10.1016\/j.joim.2022.09.006_b0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0015","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.joim.2022.09.006_b0020","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1007\/s13277-016-4972-7","article-title":"Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy","volume":"37","author":"Bhattacharya","year":"2016","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.joim.2022.09.006_b0030","series-title":"Cytotoxicity","article-title":"Cytotoxic colchicine alkaloids: from plants to drugs","author":"Kurek","year":"2018"},{"issue":"7","key":"10.1016\/j.joim.2022.09.006_b0035","first-page":"892","article-title":"Colchicine semisynthetics: chemotherapeutics for cancer?","volume":"20","author":"Sivakumar","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.joim.2022.09.006_b0040","first-page":"19","article-title":"Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines","volume":"13","author":"De Vincenzo","year":"1998","journal-title":"Anticancer Drug Des"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0045","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s002800051053","article-title":"Multidrug resistance: molecular mechanisms and clinical relevance","volume":"40","author":"Ling","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.joim.2022.09.006_b0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"20","key":"10.1016\/j.joim.2022.09.006_b0055","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1039\/C5OB00406C","article-title":"Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability","volume":"13","author":"Singh","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.joim.2022.09.006_b0060","series-title":"Basic science methods for clinical researchers","first-page":"151","article-title":"Cell culture: growing cells as model systems in vitro","author":"Segeritz","year":"2017"},{"issue":"3","key":"10.1016\/j.joim.2022.09.006_b0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jmi.12133","article-title":"Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques","volume":"255","author":"Atale","year":"2014","journal-title":"J Microsc"},{"key":"10.1016\/j.joim.2022.09.006_b0075","doi-asserted-by":"crossref","unstructured":"Kaleem S, Siddiqui S, Siddiqui HH, Hussain A, Arshad M, Akhtar J, et al. Eupalitin induces apoptosis in prostate carcinoma cells through ROS generation and increase of caspase\u20103 activity. Cell Biol Int 2016;40(2):196\u2013203.","DOI":"10.1002\/cbin.10552"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0080","first-page":"262","article-title":"Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K\/AKT signaling pathway","volume":"25","author":"Hua","year":"2020","journal-title":"J BUON"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0085","doi-asserted-by":"crossref","first-page":"e1459","DOI":"10.1038\/cddis.2014.387","article-title":"Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin","volume":"5","author":"Majeed","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.joim.2022.09.006_b0090","doi-asserted-by":"crossref","unstructured":"Fazeela Mahaboob Begum SM, Chitra K, Joseph B, Sundararajan R, S H. Gelidiella acerosa inhibits lung cancer proliferation. BMC Complement Altern Med 2018;18(1):104.","DOI":"10.1186\/s12906-018-2165-1"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0095","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181802","article-title":"Anticancer effects and underlying mechanism of colchicine on human gastric cancer cell lines in vitro and in vivo","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.joim.2022.09.006_b0100","first-page":"21","article-title":"Clonogenic cell survival assay","volume":"vol 110","author":"Munshi","year":"2005"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-016-2925-6","article-title":"Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors","volume":"16","author":"Pawlak","year":"2016","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0110","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1080\/15548627.2019.1596476","article-title":"Alborixin clears amyloid-\u03b2 by inducing autophagy through PTEN-mediated inhibition of the AKT pathway","volume":"15","author":"Wani","year":"2019","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.joim.2022.09.006_b0115","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/mc.22457","article-title":"A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis","volume":"55","author":"Hussain","year":"2016","journal-title":"Mol Carcinog"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0120","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ptr.6123","article-title":"Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: a possible risk for long-term use","volume":"32","author":"Dogra","year":"2018","journal-title":"Phytother Res"},{"key":"10.1016\/j.joim.2022.09.006_b0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jchromb.2017.06.015","article-title":"Development and validation of a highly sensitive LC-ESI-MS\/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development","volume":"1060","author":"Magotra","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.joim.2022.09.006_b0130","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/acs.jmedchem.7b01765","article-title":"Discovery and preclinical development of IIIM-290, an orally active potent cyclin-dependent kinase inhibitor","volume":"61","author":"Bharate","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.joim.2022.09.006_b0135","doi-asserted-by":"crossref","unstructured":"Kumar A, Singh B, Mahajan G, Sharma PR, Bharate SB, Mintoo MJ, et al. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells. 2016; 37(10): 13121\u201336.","DOI":"10.1007\/s13277-016-5160-5"},{"issue":"2","key":"10.1016\/j.joim.2022.09.006_b0140","first-page":"68","article-title":"Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines","volume":"32","author":"Lin","year":"2016","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0145","doi-asserted-by":"crossref","first-page":"e87064","DOI":"10.1371\/journal.pone.0087064","article-title":"Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells","volume":"9","author":"Larocque","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.joim.2022.09.006_b0150","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1134\/S0006297915110012","article-title":"Mechanisms of apoptosis","volume":"80","author":"Savitskaya","year":"2015","journal-title":"Biochemistry (Mosc)"},{"issue":"12","key":"10.1016\/j.joim.2022.09.006_b0155","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/cr.2009.98","article-title":"Outer membrane VDAC1 controls permeability transition of the inner mitochondrial membrane in cellulo during stress-induced apoptosis","volume":"19","author":"Tomasello","year":"2009","journal-title":"Cell Res"},{"issue":"Pt 19","key":"10.1016\/j.joim.2022.09.006_b0160","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1242\/jcs.073643","article-title":"Regulation of the Apaf-1-caspase-9 apoptosome","volume":"123","author":"Bratton","year":"2010","journal-title":"J Cell Sci"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0165","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1210\/jcem.86.10.7860","article-title":"Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel","volume":"86","author":"Pan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joim.2022.09.006_b0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/128_2008_11","article-title":"Microtubule-destabilizing agents: structural and mechanistic insights from the interaction of colchicine and vinblastine with tubulin","volume":"286","author":"Gigant","year":"2009","journal-title":"Top Curr Chem"},{"issue":"8","key":"10.1016\/j.joim.2022.09.006_b0175","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/bph.12431","article-title":"Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway","volume":"171","author":"Roy","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"16","key":"10.1016\/j.joim.2022.09.006_b0180","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-12-1424","article-title":"Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy","volume":"19","author":"Nogueira","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.joim.2022.09.006_b0185","first-page":"794","article-title":"Production of large amounts of hydrogen peroxide by human tumor cells","volume":"51","author":"Szatrowski","year":"1991","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.joim.2022.09.006_b0190","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.joim.2022.09.006_b0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.joim.2022.09.006_b0200","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-06-3914","article-title":"Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species","volume":"67","author":"Alexandre","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.joim.2022.09.006_b0205","doi-asserted-by":"crossref","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","article-title":"The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.joim.2022.09.006_b0210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"10.1016\/j.joim.2022.09.006_b0215","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","article-title":"Targeting the MDM2-p53 interaction for cancer therapy","volume":"14","author":"Shangary","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"6630","key":"10.1016\/j.joim.2022.09.006_b0220","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.joim.2022.09.006_b0225","first-page":"1001","article-title":"The MDM2-p53 interaction","volume":"1","author":"Moll","year":"2003","journal-title":"Mol Cancer Res"},{"issue":"4","key":"10.1016\/j.joim.2022.09.006_b0230","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.joim.2022.09.006_b0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcp.2006.04.031","article-title":"In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells","volume":"72","author":"Chen","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.joim.2022.09.006_b0240","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.molcel.2004.11.002","article-title":"DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter","volume":"16","author":"Clair","year":"2004","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0245","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(08)70209-2","article-title":"Targeted manipulation of apoptosis in cancer treatment","volume":"9","author":"Call","year":"2008","journal-title":"Lancet Oncol"},{"issue":"33","key":"10.1016\/j.joim.2022.09.006_b0250","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1038\/onc.2009.170","article-title":"Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms","volume":"28","author":"Satyanarayana","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.joim.2022.09.006_b0255","first-page":"309","article-title":"Tubulin and microtubules as targets for anticancer drugs","volume":"5","author":"Hadfield","year":"2003","journal-title":"Prog Cell Cycle Res"},{"issue":"4","key":"10.1016\/j.joim.2022.09.006_b0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.joim.2022.09.006_b0265","doi-asserted-by":"crossref","first-page":"e4470","DOI":"10.1371\/journal.pone.0004470","article-title":"Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors","volume":"4","author":"Abdullah","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/excr.1995.1147","article-title":"Colchicine induces apoptosis in cerebellar granule cells","volume":"218","author":"Bonfoco","year":"1995","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.67.1.481","article-title":"Phosphoinositide kinases","volume":"67","author":"Fruman","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.joim.2022.09.006_b0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.joim.2022.09.006_b0285","first-page":"299","article-title":"Targeting the PI3K\/AKT\/mTOR signaling axis in children with hematologic malignancies","volume":"14","author":"Barrett","year":"2012","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.joim.2022.09.006_b0290","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/pr.110.004051","article-title":"Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory\/autoimmune diseases and hematological malignancies","volume":"64","author":"Foster","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"25","key":"10.1016\/j.joim.2022.09.006_b0295","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.joim.2022.09.006_b0300","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/01635581.2020.1781202","article-title":"Edible sword bean extract induces apoptosis in cancer cells in vitro and inhibits ascites and solid tumor development in vivo","volume":"73","author":"Abeesh","year":"2021","journal-title":"Nutr Cancer"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0305","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/mc.23332","article-title":"A rohitukine derivative IIIM-290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells","volume":"60","author":"Mintoo","year":"2021","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.joim.2022.09.006_b0310","doi-asserted-by":"crossref","first-page":"118941","DOI":"10.1016\/j.carbpol.2021.118941","article-title":"Self-assembled chitosan derived microparticles inhibit tumor angiogenesis and induce apoptosis in Ehrlich-ascites-tumor bearing mice","volume":"278","author":"Punarvasu","year":"2022","journal-title":"Carbohydr Polym"},{"issue":"10","key":"10.1016\/j.joim.2022.09.006_b0315","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1535-7163.MCT-06-0391","article-title":"Tumor models for efficacy determination","volume":"5","author":"Teicher","year":"2006","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209549642200108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209549642200108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:28:26Z","timestamp":1778837306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209549642200108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S209549642200108X"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2022.09.006","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}